Preetam Kaushik

2 weeks ago | breakingcancernews.com | Preetam Kaushik

Cancerous tumors have complex structures that exhibit dynamic microenvironments and intricate signalling networks. Thanks to cellular mutations, accurately predicting how they react to specific drugs and treatment protocols is often a herculean task. While animal testing can help us in the initial testing stages, it is not 100% perfect at replicating the characteristics of a tumor microenvironment in the human body.

3 weeks ago | breakingcancernews.com | Preetam Kaushik

When a disease has the word “acute” in the title, it usually implies a bleak prognosis. This is especially true in the case of cancers. Acute Myeloid Leukemia (AML) is a classic example. It is a type of blood cancer that affects the myeloid cells inside the bone marrow. With a median patient age of 68, AML is more common in older adults, but can also affect younger individuals. It is one of the most common types of adult leukemia, with around 20,000 new cases reported each year in the United States.

3 weeks ago | breakingcancernews.com | Preetam Kaushik

Tattooing is one of the oldest forms of body art and self-expression known to humans. Otzi the Iceman, whose 3,300-year-old body was found perfectly preserved in the Alps, had over 60 simple tattoos made by rubbing soot into tiny cuts in the skin.  Cultures and civilizations around the globe have used tattoos as a part of self-expression, religious and spiritual traditions, and as a form of tribal identification.

1 month ago | breakingcancernews.com | Preetam Kaushik

Lung cancer has been strongly associated with cigarette smoking, since at least the 1960s. While smoking is still the leading cause of lung cancer cases worldwide, it is far from the only factor. A recent concerning trend is the rise in lung cancer among non-smokers. Among non-smokers, a combination of factors is responsible for elevated lung cancer risk. Long-term exposure to air pollution is a major concern, particularly in Asia. Occupational exposure to carcinogens can also play a role.

1 month ago | breakingcancernews.com | Preetam Kaushik

Ovarian cancer is the deadliest form of gynecological cancer that kills an estimated 12,700 women each year in the United States. Since 70% of all new cases are diagnosed at advanced stages, the risk of death within 5 years is quite high (60% at stage III and 83% at stage IV). The standard first-line treatment for advanced ovarian cancer is surgery (if possible), followed by chemotherapy using platinum-based drugs like Carboplatin.